REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Au Benu (Serbia)

Main Activities: Pharmacies and Drug Stores
Full name: Au Benu Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Au Benu is an enterprise located in Serbia, with the main office in Beograd-Cukarica. The company operates in the Pharmacies and Drug Stores industry. It currently has a total number of 2,058 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 16.49% in 2023. During that time, Au Benu’s total assets grew by 11.95%. The enterprise’s net profit margin decreased by 0.36% in 2023.

Headquarters
Bore Stankovica Makis 2
Beograd-Cukarica; Beograd-Cukarica;

Contact Details: Purchase the Au Benu report to view the information.

Website: http://www.apotekapharmacity.rs

Basic Information
Total Employees:
Purchase the Au Benu report to view the information.
Outstanding Shares:
Purchase the Au Benu report to view the information.
Registered Capital:
Purchase the Au Benu report to view the information.
Financial Auditors:
Purchase the Au Benu report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Au Benu report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
16.49%▲
Total operating revenue
16.86%▲
Operating profit (EBIT)
-5.49%▼
EBITDA
1.58%▲
Net Profit (Loss) for the Period
4.82%▲
Total assets
11.95%▲
Total equity
53.02%▲
Operating Profit Margin (ROS)
-0.91%▼
Net Profit Margin
-0.36%▼
Return on Equity (ROE)
-15.22%▼
Debt to Equity Ratio
-81.68%▼
Quick Ratio
0.07%▲
Cash Ratio
0.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo